Aedifica: The Well-Covered 6.9% Yield Is Too Difficult To Ignore (OTCMKTS:AEDFF)
Aedifica: The Well-Covered 6.9% Yield Is Too Difficult To Ignore
Source link
Aedifica: The Well-Covered 6.9% Yield Is Too Difficult To Ignore
Source link
by Calculated Risk on 12/05/2024 02:39:00 PM On Friday at 8:30 AM ET, the BLS will release the employment report for November. The consensus is for 183,000 jobs added, and for the unemployment rate to be unchanged at 4.1%. There were 12,000 jobs added in October, and the unemployment rate was at 4.1%. From Goldman…
June 24, 2024 by Leave a Comment Last Updated on June 24, 2024 by [#item_full_content] Like this: Like Loading… Related Filed Under: biotech news, News Reader Interactions This site uses Akismet to reduce spam. Learn how your comment data is processed. Source link
by Calculated Risk on 9/12/2024 09:51:00 AM From CoreLogic: CoreLogic: US Homeowners See Equity Gains Continue to Climb, but at a Slower Pace in Q2 CoreLogic® … today released the Homeowner Equity Report (HER) for the second quarter of 2024. The report shows that U.S. homeowners with mortgages (which account for roughly 62% of all properties) saw…
share this article! [#item_full_content] Read More share this article! Source link
1. No 2. Earlier today, Eisai Co., Ltd , a company incorporated in Japan and listed on the Tokyo Stock Exchange, announced that its confirmatory phase 3 Clarity AD study of experimental therapy, Lecanemab, met primary endpoint, showing a statistically significant reduction of clinical decline in a global clinical study of 1,795 participants with early…
share this article! [#item_full_content] Read More share this article! Source link